Journal Lieberman L, Castro D, Bhatt A, Guyer F
As of January 2026, 13 states (Delaware, Kansas, Massachusetts, Michigan, Minnesota, Mississippi, Missouri, North Carolina, Rhode Island, Tennessee, Utah, Virginia, and Wisconsin) cover GLP-1 receptor agonists (such as Wegovy) for weight loss
Nounu A, Kar SP, Relton CL, Richmond RC
Researchers found that 86.4% of adults who took semaglutide were able to lose at least 5% of their baseline body weight during the trial, compared with only 31.5% who only followed lifestyle interventions
The shift from a dark band to no band was so dramatic that I took another test after the no band, and then, of course, the next day, and the next day, this kind of thing
Receptor density and signalling efficiency in the area postrema vary across the 24-hour cycle